Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Silo Pharma (QB) (SILO)

Silo Pharma Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SILO
DateTimeSourceHeadlineSymbolCompany
29/06/202321:32Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
26/05/202321:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
18/05/202321:21Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
15/02/202321:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
14/02/202321:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SILOSilo Pharma Inc (QB)
03/02/202313:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
31/01/202321:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
20/01/202313:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
15/12/202221:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
01/12/202221:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
10/11/202221:49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
18/10/202222:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
30/09/202213:46Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
28/09/202221:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:SILOSilo Pharma Inc (QB)
27/09/202213:30Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)USOTC:SILOSilo Pharma Inc (QB)
27/09/202211:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:SILOSilo Pharma Inc (QB)
26/09/202221:01Edgar (US Regulatory)Securities Registration (section 12(b)) (8-a12b)USOTC:SILOSilo Pharma Inc (QB)
09/09/202211:01Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
29/08/202211:17Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
01/08/202221:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
25/07/202212:13Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SILOSilo Pharma Inc (QB)
21/06/202213:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
13/05/202221:19Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
11/03/202221:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
07/03/202222:26Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:SILOSilo Pharma Inc (QB)
14/02/202222:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:SILOSilo Pharma Inc (QB)
05/01/202223:19Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:SILOSilo Pharma Inc (QB)
15/12/202118:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SILOSilo Pharma Inc (QB)
10/11/202122:15Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SILOSilo Pharma Inc (QB)
27/10/202121:31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SILOSilo Pharma Inc (QB)
 Showing the most relevant articles for your search:USOTC:SILO